NTRK Fusion Gene Positive Advanced Solid Tumors Market

NTRK Fusion Gene Positive Advanced Solid Tumors Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

NTRK Fusion Gene Positive Advanced Solid Tumors Market Overview

A patient with tumors who has mutated genes NTRK is called NTRK fusion gene positive tumors. Although NTRK fusions are rare and account to nearly 1% of solid tumors, the exact frequency is quite unclear. DNA Next Generation Sequencing (NSG) technology is a precise method to detect NTRK fusion genes. It has high specificity and sensitivity. It can detects gene partners that may have high clinical implications in treatment. Currently Commercialized techniques such as DNA NGS panels, Foundation One may not detect NTRK fusions.  

NTRK Fusion Gene Positive Advanced Solid Tumors Market: Drivers and Restraints

NTRK fusions has higher prevalence rate as they are found in most of solid cancer types. This is expected to drives NTRK fusion gene positive advanced solid tumors market. NTRK is a unique gene which has implications in many types of cancers and the development of latest drugs is expected to drive NTRK fusion gene positive advanced solid tumors market. However, Poor healthcare infrastructure and high costs associated with genetic screening of NTRK fusion genes may hamper growth of NTRK fusion gene positive advanced solid tumors market in the future. 

NTRK Fusion Gene Positive Advanced Solid Tumors Market: Overview

The global NTRK fusion gene positive advanced solid tumors market is estimated to show rapid growth over forecast period owing to technical advancements. Early screening and detection of NTRK mutation genes in people will contribute to NTRK fusion gene positive advanced solid tumors market. Global NTRK fusion gene positive advanced solid tumors market has high potential due to development of novel therapeutics in near future for treating different types of cancers. Recently in 2019, FDA approved NTRK inhibitors like Entrectinib manufactured by Genentech Inc., for effective treatment of NTRK fusion gene positive advanced solid tumors.

NTRK Fusion Gene Positive Advanced Solid Tumors Market: Regional Overview

The global NTRK fusion gene positive advanced solid tumors market is expected to be dominated by North America owing to rising cancer clinical research and development activities. Latin America market is emerging in NTRK fusion gene positive advanced solid tumors market due to increased spending on healthcare infrastructure. Europe market is expected to be the second most growing region in the global NTRK fusion gene positive advanced solid tumors market owing to early diagnosis and treatment adoption. NTRK fusion gene positive advanced solid tumors market in East Asia and South Asia is expected to show significant growth due to improving healthcare infrastructure. Middle East and Africa market is expected to be least lucrative region in the NTRK fusion gene positive advanced solid tumors market due to poor healthcare facilities and less disease screening facilities.

NTRK Fusion Gene Positive Advanced Solid Tumors Market: Key Players

Examples of some of the market participants in NTRK fusion gene positive advanced solid tumors market identified across the value chain includes Bayer A.G., Merck & Co., Inc., F. Hoffmann-La Roche AG, Glaxosmithkline plc, Pfizer Inc., Plexxikon, Daiichi Sankyo Company Limited, Deciphera Pharmaceuticals, Inc., Eli Lilly and company, Exelixis, Inc., Cephalon, Inc., and others.

The research report on NTRK fusion gene positive advanced solid tumors market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and, statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on NTRK fusion gene positive advanced solid tumors market provides analysis and information according to market segments such as geographies, application, and end user.  

The report covers exhaust analysis on NTRK Fusion Gene Positive Advanced Solid Tumors Market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report on NTRK Fusion Gene Positive Advanced Solid Tumors Market includes regional analysis:

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on NTRK fusion gene positive advanced solid tumors market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NTRK Fusion Gene Positive Advanced Solid Tumors Market: Segmentation

The global NTRK fusion gene positive advanced solid tumors market is classified on the basis of Indication and End User.

Based on indication, NTRK fusion gene positive advanced solid tumors market is segmented into the following:

  • NTRK 1 Fusion Tumors
  • NTRK 2 Fusion Tumors
  • NTRK 3 Fusion Tumors

Based on end user, NTRK fusion gene positive advanced solid tumors market is segmented into the following:

  • Hospitals
  • Specialty Clinics
  • Cancer Centers
  • Cancer Research Institutes

Report on NTRK Fusion Gene Positive Advanced Solid Tumors Market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports

Recommendations

NTRK Fusion Gene Positive Advanced Solid Tumors Market